Implications of the ISCHEMIA trial on the practice of surgical myocardial revascularization

Marc Ruel; Louise Y Sun; Michael E Farkouh; Mario F Gaudino

doi:10.1016/j.jtcvs.2020.07.123

Implications of the ISCHEMIA trial on the practice of surgical myocardial revascularization

J Thorac Cardiovasc Surg. 2021 Jul;162(1):90-99. doi: 10.1016/j.jtcvs.2020.07.123. Epub 2020 Sep 9.

Authors

Marc Ruel¹, Louise Y Sun², Michael E Farkouh³, Mario F Gaudino⁴

Affiliations

¹ University of Ottawa Heart Institute, University of Ottawa, Ottawa, Ontario, Canada. Electronic address: mruel@ottawaheart.ca.
² University of Ottawa Heart Institute, University of Ottawa, Ottawa, Ontario, Canada.
³ Peter Munk Cardiac Centre and Heart and Stroke Richard Lewar Centre, University of Toronto, Toronto, Ontario, Canada.
⁴ New York Presbyterian Hospital, Weill Cornell Medicine, New York, NY.

PMID: 33069424
DOI: 10.1016/j.jtcvs.2020.07.123

No abstract available

Keywords: clinical trials; coronary angiography; coronary artery bypass grafting; coronary artery disease; observational studies; optimal medical therapy; outcomes; percutaneous coronary intervention; surgery.

Publication types

Editorial

MeSH terms

Adult
Clinical Trials as Topic
Coronary Angiography
Coronary Artery Disease / surgery*
Female
Humans
Male
Middle Aged
Myocardial Revascularization*
Percutaneous Coronary Intervention
Treatment Outcome